Coronavirus surges in China, 2,591 new locally transmitted cases reported

Witnessing a COVID surge, China on Tuesday reported 2,591 locally transmitted COVID-19 cases, the National Health Commission said Wednesday.

covid
Of the new local infections, 2,320 were reported in the province of Jilin, 110 in Fujian, 36 in Liaoning, 24 each in Tianjin and Shandong, 15 in Guangdong and 13 in Heilongjiang. Photo: Unsplash/Fusion Medical Animation
ANI Asia
2 min read Last Updated : Mar 23 2022 | 8:28 AM IST

Witnessing a COVID surge, China on Tuesday reported 2,591 locally transmitted COVID-19 cases, the National Health Commission said Wednesday.

Of the new local infections, 2,320 were reported in the province of Jilin, 110 in Fujian, 36 in Liaoning, 24 each in Tianjin and Shandong, 15 in Guangdong and 13 in Heilongjiang, Xinhua reported.

The rest of the cases were reported in 12 other provincial-level regions, including Hebei and Jiangxi.

According to the commission, a total of 76 imported COVID-19 cases were reported on Tuesday. It further said that three suspected cases, all imported, were reported in Shanghai, as per Xinhua.

Meanwhile, the COVID-19 pandemic situation in China continues to heat up as more than 20 provinces and cities have imposed travel bans and lockdowns.

The situation in more than 20 provinces and cities including Jilin, Hebei, Guangdong, and Shanghai has deteriorated.

China is facing mounting pressure to guard against infections amid a recent surge in cases throughout the country.

Earlier, Chinese President Xi Jinping has said that Beijing will stick to its "zero Covid-19" policy, days after National Health Commission (NHC) released new guidelines easing its control measures.NHC had uploaded a new document on its website. Titled the Novel Coronavirus Diagnosis And Treatment Plan, it was the ninth revision to a document setting out COVID-19 policy for the country of 1.4 billion.

China's zero-COVID policy is pushing cash-strapped local governments to the brink amid rising health care costs and efforts to control debt.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineChina

First Published: Mar 23 2022 | 8:28 AM IST

Next Story